tangeretin has been researched along with tamoxifen in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bracke, ME; Mareel, MM; Van Roy, FM | 1 |
| Boterberg, T; Bracke, ME; Depypere, HT; Mareel, MM; Nuytinck, M; Serreyn, R; Van Marck, VL; Vanluchene, E; Vennekens, KM | 1 |
| Boterberg, T; Bracke, ME; Depypere, HT; Mareel, MM; Nuytinck, M; Serreyn, R; Vennekens, K | 1 |
| Boterberg, T; Brack, ME; Depypere, HT; Leclercq, G; Mareel, MM; Stove, C | 1 |
2 review(s) available for tangeretin and tamoxifen
| Article | Year |
|---|---|
The E-cadherin/catenin complex in invasion and metastasis.
Topics: Adenocarcinoma; alpha Catenin; Animals; beta Catenin; Breast Neoplasms; Cadherins; Cell Polarity; Cytoskeletal Proteins; Cytoskeleton; Desmoplakins; Dogs; Epithelium; Fetal Proteins; Flavones; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Macromolecular Substances; Multigene Family; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Protein Conformation; Receptor, IGF Type 1; Structure-Activity Relationship; Tamoxifen; Trans-Activators; Tretinoin; Tumor Cells, Cultured | 1996 |
The citrus methoxyflavone tangeretin affects human cell-cell interactions.
Topics: Animals; beta Catenin; Breast Neoplasms; Cadherins; Carcinoma; Cell Adhesion; Citrus; Contraindications; Cytoskeletal Proteins; Drug Interactions; Estrogen Receptor Modulators; Female; Flavones; Flavonoids; Humans; Immunosuppressive Agents; Killer Cells, Natural; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Proteins; Tamoxifen; Trans-Activators; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
2 other study(ies) available for tangeretin and tamoxifen
| Article | Year |
|---|---|
Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Drug Synergism; Female; Flavones; Flavonoids; Gene Expression Regulation, Neoplastic; Killer Cells, Natural; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Plant Extracts; Tamoxifen; Tumor Cells, Cultured | 1999 |
Inhibition of tamoxifen's therapeutic benefit by tangeretin in mammary cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Female; Flavones; Flavonoids; Food-Drug Interactions; Mammary Neoplasms, Experimental; Mice; Tamoxifen | 2000 |